(a) Specifications. Each milliliter of solution contains 5.0 milligrams atipamezole hydrochloride.
(b) Sponsor. See No. 052483 in Sec. 510.600(c) of this chapter.
(c) Conditions of use in dogs--(1) Amount. Inject intramuscularly the same volume as that of dexmedetomidine or medetomidine used.
(1) Amount. Inject intramuscularly the same volume as that of dexmedetomidine or medetomidine used.
(2) Indications for use. For reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride or medetomidine hydrochloride.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [61 FR 48830, Sept. 17, 1996, as amended at 64 FR 71640, Dec. 22, 1999; 72 FR 264, Jan. 4, 2007]